Gary W. Christianson
Keine laufenden Positionen mehr
Karriereverlauf von Gary W. Christianson
Ehemalige bekannte Positionen von Gary W. Christianson
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CASCADIAN THERAPEUTICS INC (USA) | Geschäftsführer | 01.07.2007 | 09.03.2018 |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | Geschäftsführer | 17.07.2007 | 11.12.2007 |
GSK PLC | Corporate Officer/Principal | 01.01.2005 | 01.01.2007 |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Corporate Officer/Principal | 01.10.1999 | 01.01.2005 |
Ausbildung von Gary W. Christianson
Montana State University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Kanada | 2 |
Vereinigtes Königreich | 2 |
Operativ
Corporate Officer/Principal | 2 |
Chief Operating Officer | 2 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 4 |
Health Services | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
GSK PLC | Health Technology |
Private Unternehmen | 3 |
---|---|
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Health Technology |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | Health Services |
Cascadian Therapeutics LLC
Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Cascadian Therapeutics LLC is a clinical-stage biopharmaceutical company, which focuses on the development of therapeutic products for the treatment of cancer. Its product ONT-380, is an orally active and selective small-molecule HER2 inhibitor. The firm also develops preclinical product candidates in oncology using Chk1 kinase inhibitor and protocell technology. The company was founded on September 7, 2007 and is headquartered in Bothell, WA. | Health Technology |
- Börse
- Insiders
- Gary W. Christianson
- Erfahrung